The Laughlin Family Foundation Awards $155,000 to Enhance and Support Innovative Research and Education for Rare Gynecologic Cancers to Various Recipients
FOR IMMEDIATE RELEASE, June 12, 2025— The Laughlin Family Foundation awards over $155,000 to support various research and education grants for endometrial cancers, one of the only malignancies on the rise in both incidence and mortality, due largely to a lack of funding for innovative research.
For a second consecutive year, The Laughlin Family Foundation funds a $ 55,000.00 Young Investigators research grant with a focus on high grade uterine serous to the Foundation for Women’s Cancers (FWC). The grant, awarded to Dr. Anh Nguyen, University of Chicago, will provide critical research to determine if new treatments for certain kinds of new medications can be more effective in treating serous cancers for women with HER-2 mutations. The results of this research will help lay the groundwork for new clinical trials which are greatly needed before new, better and more effective options can become available.
Additionally, The Laughlin Family Foundation continues their support of Dr. Amanda Nickles Fader, Vice Chair of Gynecological Surgical Operations at Johns Hopkins and Director of the Center for Gynecologic Cancers, by awarding her $100,000 to advance research and education for rare gynecologic cancers. This is the third grant that the Foundation has awarded Dr. Fader.
“We are excited and thankful for Dr. Fader and Dr. Nguyen, who are really trying to move the needle in the field of gynecologic oncology. Both os these doctors believe in our same mission to help see an end to these deadly diseases that are affecting women worldwide,” said Linda Laughlin.
”We believe that research saves lives, and trust that the very valuable work that is being done with these grants will lead to better outcomes for women diagnosed with endometrial cancer.”
Endometrial cancer is one of the only malignancies on the rise in both incidence and mortality, and it on track to become the deadliest gynecologic cancer this year. Due to the lack of funding, research, and information on endometrial cancer, patients are left with few treatment options and poor outcomes.
